IP Library Granted Patent US 8,129,418
Granted Patent B2
US 8,129,418 · App. 12/677,078 · Granted Mar 6, 2012

Macrocyclic compounds and methods of treatment

Assignees: University of Florida Research Foundation; Smithsonian Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,129,418
App. No.
12/677,078
Granted
Mar 6, 2012
Kind
B2
Abstract

The instant invention describes macrocyclic compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.

Claims (19)

1. A compound according to Formula I:

wherein:

each R is independently H or optionally substituted alkyl;

each R 1 is independently H, or optionally substituted alkyl;

each R 2 is independently H, optionally substituted alkyl, or C(O)R;

each R 3 is independently H, optionally substituted alkyl, C(O)OR, or C(O)NRR;

or a pharmaceutically acceptable salt thereof C(O)NRR;

and pharmaceutically acceptable salts, solvate, or hydrate thereof.

2. The compound of claim 1 , wherein R 3 and R 4 are H.

3. The compound of claim 2 wherein R 1 is isopropyl.

4. The compound of claim 1 wherein the compound is any of Compounds 1-8

5. The compound of claim 1 wherein the compound is largazole.

6. The compound of claim 1 , wherein R 2 is alkyl.

7. The compound of claim 6 , wherein R 2 is alkylC(O)—.

8. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

9. The pharmaceutical composition of claim 8 , wherein the compound of claim 1 is any of Compounds 1-8,

and a pharmaceutically acceptable carrier.

10. The pharmaceutical composition of claim 9 further comprising an additional therapeutic agent.

11. The pharmaceutical composition of claim 10 wherein the additional therapeutic agent is an anti-cancer agent, chemotherapeutic agent, an anti-angiogenesis agent, cytotoxic agent, or an anti-proliferation agent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2012
From: PAUL, VALERIE
To: SMITHSONIAN INSTITUTION
Reel/Frame 027614/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2010
From: LUESCH, HENDRIK; KANCHAN, TAORI; PAUL, VALERIE J.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
Reel/Frame 025441/0518 →
Continuity (6)
Provisional Application 60970986 · Sep 9, 2007
Provisional Application 61009903 · Jan 3, 2008
Provisional Application 61030993 · Feb 24, 2008
Provisional Application 61125542 · Apr 24, 2008
Provisional Application 61189093 · Aug 15, 2008
Related Publication 20110118323A1 · May 19, 2011